Risankizumab Concentration but not IL-22 Levels Are Associated With Clinical and Biochemical Remission in Patients With Crohn's Disease. - Roblin X; Moschetti E; Barrau M; Cheifetz AS; Papamichael K; Paul S (Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 2024)